• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羊棘球蚴病 EG95 疫苗免疫后血清学保护监测。

Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine.

机构信息

Animal Health Division, AgResearch New Zealand Limited, Palmerston North, New Zealand.

出版信息

Parasite Immunol. 2012 Jan;34(1):40-4. doi: 10.1111/j.1365-3024.2011.01341.x.

DOI:10.1111/j.1365-3024.2011.01341.x
PMID:22043983
Abstract

Although immunity to Echinococcus granulosus in sheep has been shown to be antibody-mediated and complement-dependent and can be passively transferred in colostrum, in animals vaccinated with EG95, the relationship between protection against an oral challenge infection with E. granulosus eggs and anti-EG95 IgG ELISA absorbance values at the time of challenge has not been satisfactorily proven. Using a combination of results from three EG95 vaccination trials, we have found that the IgG ELISA absorbance at the time of challenge infection explains approximately 50% (P ≤ 0·001) of the variability in the percentage protection against an oral challenge with E. granulosus eggs (transformed with arcsin).

摘要

尽管已经证明绵羊对细粒棘球蚴的免疫力是抗体介导和补体依赖的,并可以在初乳中被动转移,但在接种 EG95 的动物中,针对棘球蚴卵口服感染的保护与 EG95 IgG ELISA 吸光度值在挑战时之间的关系尚未得到令人满意的证明。使用来自三项 EG95 疫苗接种试验的结果组合,我们发现,在挑战感染时的 IgG ELISA 吸光度值解释了大约 50%(P ≤ 0·001)的口服棘球蚴卵挑战的保护百分比的变异性(用反正弦转换)。

相似文献

1
Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine.羊棘球蚴病 EG95 疫苗免疫后血清学保护监测。
Parasite Immunol. 2012 Jan;34(1):40-4. doi: 10.1111/j.1365-3024.2011.01341.x.
2
Antigenic differences between the EG95-related proteins from Echinococcus granulosus G1 and G6 genotypes: implications for vaccination.细粒棘球蚴 G1 和 G6 基因型相关蛋白的抗原差异:对疫苗接种的影响。
Parasite Immunol. 2013 Feb;35(2):99-102. doi: 10.1111/pim.12009.
3
Pilot vaccination project for the control of hydatid disease in Matera province (southern Italy).意大利南部马泰拉省控制包虫病的试点疫苗接种项目。
Parassitologia. 2004 Dec;46(4):421.
4
Vaccination of bovines against Echinococcus granulosus (cystic echinococcosis).牛棘球蚴病(包虫病)的疫苗接种。
Vaccine. 2012 Apr 26;30(20):3076-81. doi: 10.1016/j.vaccine.2012.02.073. Epub 2012 Mar 8.
5
Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: Humoral response to the vaccine.阿根廷内乌肯针对绵羊囊型包虫病的EG95疫苗现场试验:对该疫苗的体液免疫反应
Parasitol Int. 2017 Jun;66(3):258-261. doi: 10.1016/j.parint.2017.01.020. Epub 2017 Feb 4.
6
Serology and longevity of immunity against Echinococcus granulosus in sheep and llama induced by an oil-based EG95 vaccine.油基EG95疫苗诱导绵羊和美洲驼抗细粒棘球绦虫免疫的血清学及免疫持久性
Parasite Immunol. 2016 Aug;38(8):496-502. doi: 10.1111/pim.12325. Epub 2016 Jun 13.
7
Preliminary evaluation of a thermosensitive chitosan hydrogel for Echinococcus granulosus vaccine delivery.用于细粒棘球绦虫疫苗递送的热敏壳聚糖水凝胶的初步评估。
Vet Parasitol. 2017 Mar 15;236:117-120. doi: 10.1016/j.vetpar.2017.02.007. Epub 2017 Feb 14.
8
Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virus.利用重组痘苗病毒向小鼠和绵羊体内递送细粒棘球绦虫抗原 EG95。
Parasite Immunol. 2012 Jun;34(6):312-7. doi: 10.1111/j.1365-3024.2012.01360.x.
9
Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts.动物中间宿主细粒棘球绦虫感染的免疫与疫苗防控
Parassitologia. 2004 Jun;46(1-2):27-31.
10
Pilot Field Trial of the EG95 Vaccine Against Ovine Cystic Echinococcosis in Rio Negro, Argentina: Second Study of Impact.阿根廷内乌肯针对绵羊囊型包虫病的EG95疫苗现场试验:影响的第二项研究
PLoS Negl Trop Dis. 2015 Oct 30;9(10):e0004134. doi: 10.1371/journal.pntd.0004134. eCollection 2015.

引用本文的文献

1
Synthetic rEg.P29 Peptides Induce Protective Immune Responses Against in Mice.合成的重组P29肽诱导小鼠针对[具体疾病或病原体,原文未明确]产生保护性免疫反应。
Vaccines (Basel). 2025 Mar 3;13(3):266. doi: 10.3390/vaccines13030266.
2
Optimizing sheep B-cell epitopes in recombinant antigen P29 for vaccine development.优化重组抗原 P29 中的绵羊 B 细胞表位用于疫苗开发。
Front Immunol. 2024 Aug 14;15:1451538. doi: 10.3389/fimmu.2024.1451538. eCollection 2024.
3
Successful control of Echinococcosis in Argentina and Chile through a One Health approach, including vaccination of the sheep intermediate host.
通过“同一健康”方法成功控制阿根廷和智利的棘球蚴病,包括对绵羊中间宿主进行疫苗接种。
Parasitology. 2024 Nov;151(13):1401-1405. doi: 10.1017/S0031182024000519.
4
Recombinant antigen P29 of induces Th1, Tc1, and Th17 cell immune responses in sheep.重组抗原 P29 诱导绵羊产生 Th1、Tc1 和 Th17 细胞免疫应答。
Front Immunol. 2023 Dec 11;14:1243204. doi: 10.3389/fimmu.2023.1243204. eCollection 2023.
5
Immunogenicity of peptide-based vaccine composed of epitopes from Echinococcus granulosus rEg.P29.由细粒棘球绦虫重组抗原rEg.P29的表位组成的基于肽的疫苗的免疫原性
FASEB J. 2023 Apr;37(4):e22819. doi: 10.1096/fj.202201636R.
6
Assessment of the Vaccination Program against Cystic Echinococcosis in Sheep in the Pehuenche Community of Central Chile.智利中部佩温切社区绵羊囊型包虫病疫苗接种计划评估
Animals (Basel). 2022 Mar 8;12(6):679. doi: 10.3390/ani12060679.
7
Immunization of sheep against with protoscolex tegumental surface antigens.用原头节皮层表面抗原对绵羊进行免疫。
Vet World. 2017 Aug;10(8):854-858. doi: 10.14202/vetworld.2017.854-858. Epub 2017 Aug 3.
8
Immunoprotection of recombinant Eg.P29 against Echinococcus granulosus in sheep.重组Eg.P29对绵羊细粒棘球绦虫的免疫保护作用
Vet Res Commun. 2016 Jun;40(2):73-9. doi: 10.1007/s11259-016-9656-7. Epub 2016 Apr 19.
9
Activity in mice of recombinant BCG-EgG1Y162 vaccine for Echinococcus granulosus infection.重组卡介苗-细粒棘球绦虫EgG1Y162疫苗对小鼠细粒棘球绦虫感染的活性。
Hum Vaccin Immunother. 2016;12(1):170-5. doi: 10.1080/21645515.2015.1064564. Epub 2015 Aug 12.